InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Fischesser Ryan, Vice-Président Financier. Insider active across 1 company, notably Caribou Biosciences, Inc.. In total, 8 filings have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €16k. History available since 11 October 2021. The latest transaction was disclosed on 5 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
1,136 shares@ US$2.690.0014% mcap13.2% of flowCommon StockSEC:0001209191-22-027696:0
1,136 shares@ US$2.690.0013% mcap12.7% of flowCommon StockSEC:0001209191-22-019808:0
569 shares@ US$2.690.0006% mcap16.6% of flowCommon StockSEC:0001209191-22-003062
Ideal exit: 8 Oct 2022 (T+270)
569 shares@ US$2.690.0006% mcap6.2% of flowCommon StockSEC:0001209191-22-003062:0
Ideal exit: 8 Oct 2022 (T+270)
1,136 shares@ US$2.690.0013% mcap33.4% of flowCommon StockSEC:0001209191-21-070797
Ideal exit: 16 Sept 2022 (T+270)
1,136 shares@ US$2.690.0013% mcap12.4% of flowCommon StockSEC:0001209191-21-070797:0
Ideal exit: 16 Sept 2022 (T+270)
1,746 shares@ US$2.690.0019% mcap18.5% of flowCommon StockSEC:0001209191-21-060289:0
Ideal exit: 8 Jul 2022 (T+270)
1,746 shares@ US$2.6950.0% of flowCommon StockSEC:0001209191-21-060289
Ideal exit: 8 Jul 2022 (T+270)
8 of 8 declarations
About Fischesser Ryan
Ryan Fischesser is the VP of Finance and Controller at Caribou Biosciences, Inc. He oversees the company's financial operations, including budgeting and financial reporting. His expertise is essential in ensuring the financial health of the organization.
